Forward Pharma A/S (NASDAQ:FWP)’s stock price crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.93 and traded as high as $1.13. Forward Pharma A/S shares last traded at $1.11, with a volume of 4,837 shares.
Separately, ValuEngine downgraded shares of Forward Pharma A/S from a “sell” rating to a “strong sell” rating in a research note on Tuesday, July 2nd.
The business’s 50 day simple moving average is $0.93 and its two-hundred day simple moving average is $1.05.
Forward Pharma A/S operates as a biopharmaceutical company. The company focuses on developing FP187, a proprietary formulation of dimethyl fumarate used for the treatment of various inflammatory and neurological indications. Forward Pharma A/S was founded in 2005 and is headquartered in Copenhagen, Denmark.
Recommended Story: Buy-Side Analysts
Receive News & Ratings for Forward Pharma A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forward Pharma A/S and related companies with MarketBeat.com's FREE daily email newsletter.